23 February 2024
[Johannesburg, South Africa]
The Anova Health Institute is proud to announce the receipt of a substantial grant from the United States Agency for International Development (USAID), following a rigorous and competitive application process, a testament to our commitment to healthcare excellence and innovation.
With support from the U.S. Government through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and programmatically through USAID, the Anova Health Institute will partner with the Limpopo Department of Health to implement the new award, “Achieving and Sustaining HIV/TB epidemic control in Limpopo Province”. The aim of this new five-year award is to support efforts towards HIV/TB epidemic control in Capricorn and Mopani districts. The Limpopo provincial government has termed this award ‘Hanyani Bophelo programme’ which means “live life”.
This ambitious programme will be led by Dr. Lucy Ranoto, a medical professional with over ten years’ experience in the HIV/TB response in Limpopo. The programme builds upon Anova’s two-decade history of successful, impactful partnerships with the Limpopo Department of Health.
Dr. Moyahabo Mabitsi, Anova’s Chief Medical Director, expressed optimism and commitment: "Our enduring collaboration with USAID and the Department of Health reflects Anova's dedication to improving health outcomes. The Hanyani-Bophelo programme is poised to make a significant impact in the communities we serve. Throughout our journey, Anova's mission has been to enhance people’s lives and expand access to quality healthcare by developing innovative solutions, building on scientific evidence and fostering productive partnerships. This generous grant will enable us to take a significant step forward in realising Anova's vision of excellent health for all.”
USAID Southern Africa Regional Mission Director, Leslie Marbury said, "The U.S. government's support in South Africa reflects an enduring commitment to improve the well-being, prosperity, and quality of life of individuals and communities. With a focus on ending TB and HIV, our PEPFAR program catalyses transformative change, aligning with the South African government's vision. Together, we forge pathways to healthier communities and brighter futures, grounded in partnership, innovation, and compassion."
In response to this grant, Dr Mutheiwana Dombo, Deputy Director General (DDG) of the Department of Health in the Limpopo Province has shown her gratitude, “This PEPFAR grant to our partner Anova Health Institute is a welcome development. Through close collaboration with Anova we have made positive strides towards the fight against HIV/AIDS, and we believe that this grant will enable both parties to continue on this journey.”
About the Anova Health Institute:
The Anova Health Institute is a renowned healthcare NGO, at the forefront of the global battle against HIV. Recognised for its innovative and impactful approaches, Anova is making strides in increasing access to quality HIV care and treatment within the public sector. Our work in this field is not just about providing services; it's about pioneering new ways to tackle the HIV epidemic.
Our expertise extends across various critical areas: from clinical management of HIV to focusing on key populations and conducting comprehensive research on both clinical and social aspects of HIV. This multi-faceted approach enables Anova to not just respond to the HIV crisis but to actively shape the strategies and solutions that lead the way in this field. With a deep commitment to innovation and excellence, Anova is leading the charge in transforming HIV care and treatment.
As one of the largest global partners of the PEPFAR programme, Anova plays a critical role, currently supporting nearly a million individuals on antiretroviral treatment through the Department of Health services in South Africa.
Media Contact:
Sibonisiwe Dube
Head of Marketing, Anova Health Institute
060 560 2673
info@anovahealth.co.za
For more information, visit us on: www.anovahealth.co.za
